Is Distilled Water Good or Bad for you?

In a desperate search to consume a safer water source than the parasite, dioxin and chlorine ridden tap water, many resort to distilled water. Contrary to popular belief, distilled water is acidic. Distilled water is boiled until it evaporates. This vapor is then condensed back into liquid form. Hypothetically, distilled water should offer us a neutral pH balance around 7.0 to provide an alkaline and purified drinking source. However, carbon dioxide in the air dissolves into the water immediately upon exposure decreasing the pH and turning it acidic. Additionally, the distillation process strips the water of its minerals and could lead to electrolyte imbalances in the body. When you consume mineral free water over a long period of time the body will pull electrolytes from your tissues in order to function properly and eliminate waste.

Did you know that soda and other soft drinks are made with distilled water? As if soda isn’t already bad enough for us, heavy soda consumers are literally stripping and dumping large amounts of vital minerals (calcium, magnesium, and other trace minerals) into their urine. Mineral loss can quickly lead to any number of degenerative diseases including coronary heart disease, high blood pressure, arrhythmia, osteoarthritis, osteoporosis, hypothyroidism and more. Minerals are essential to our body’s pH balance and acidic environments only speed up aging and disease development. Continue reading “Is Distilled Water Good or Bad for you?”

New evidence of increased risk of death with Febuxostat (Uloric)

According to the latest CARES trial, the Gout drug Febuxostat (Uloric) failed up against Allopurinol when it came down to a combined rate of fatal and nonfatal adverse events for those that suffer with both Gout and Cardiovascular disease.  In fact, there was a significant increased risk of death for those that took this drug for Gout while also suffering from heart disease.

The trial was mandated by the FDA and consisted of 6,190 patients, 84% of which were men.  Cardiovascular risk is naturally increased in patients with Gout.  The study was attempting to look at any difference in outcome for these patients taking Febuxostat, a nonpurine xanthine oxidase inhibitor, or those taking Allopurinol, a purine base analogue xanthine oxidase inhibitor.  The patients were followed for a median of 32 months, and a maximum of 85 months.  Without diving into all of the ratio statistics, the all-cause and cardiovascular mortality rate was higher in the Febuxostat group, 34% and 22% higher respectively. Continue reading “New evidence of increased risk of death with Febuxostat (Uloric)”

error

Enjoy this blog? Please spread the word :)